Clinical Trial Update: Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease [Phase 3]

View source ↗

Summary

Phase 3 trial of velaglucerase alfa enzyme replacement therapy in Japanese patients with Gaucher disease completed; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• Velaglucerase alfa (velaglucerase alfa)

Snippet

Sponsor: Shire | Conditions: Gaucher Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-08-04